Author

C. Zhuang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Chen· 2 shared H. Zhu· 2 shared J. Chen· 2 shared J. Ma· 2 shared J. Zhang· 2 shared L. Yuan· 2 shared L. Zhang· 2 shared M. Zhou· 2 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. Chen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Intranasal delivery of NS1-deleted influenza virus vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response

L. Zhang, Y. Jiang, J. He, J. Chen, R. Qi, L. Yuan, T. Shao, C. Chen, Y. Chen, X. Wang, X. Lei, Q. Gao, C. Zhuang, M. Zhou, J. Ma, , N. Xia

This study evaluates an intranasal influenza-based vaccine against SARS-CoV-2 variants, showing it reduces inflammatory response and tissue damage through local immunity.

bioRxiv · Oct 3, 2022 · PreprintImmunology

Peramivir, an anti-influenza virus drug, exhibits potential anti-cytokine storm effects

L. Su, Z. Wang, C. Zhuang, C. Zhang, Y. Tu, D. Kong, D. Chen, W. Zhang, Y. Li

This study shows peramivir reduces cytokine storm by inhibiting NF-κB activity in macrophages and alleviates lung injury in mice.

Frontiers in Immunology · Feb 28, 2022Peer-reviewedImmunology

A live attenuated influenza virus-vectored intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2 infection

J. Chen, P. Wang, L. Yuan, L. Zhang, L. Zhang, H. Zhao, C. Chen, Y. Chen, J. Han, J. Jia, Z. Lu, J. Hong, L. Chen, C. Fan, Z. Lu, , N. Xia

This study develops an intranasal vaccine against SARS-CoV-2 using an influenza virus vector and shows it provides rapid, prolonged, and broad protection against multiple variants in hamsters.

bioRxiv · Nov 13, 2021Pathology